Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial (vol 22, pg 29, 2021)

被引：0
|
作者：
Bahadoer, R. R.
Dijkstra, E. A.
van Etten, B.
机构：
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 43 条
  • [1] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    LANCET ONCOLOGY, 2021, 22 (01): : 29 - 42
  • [2] Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.
    Hospers, Geke
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    Van de Velde, Cornelis J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial
    Nilsson, Per J.
    van Etten, Boudewijn
    Hospers, Geke A. P.
    Pahlman, Lars
    van de Velde, Cornelis J. H.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart
    Beukema, Jannet C.
    Kapiteijn, Ellen
    Marijnen, Corrie A. M.
    Nagtegaal, Iris D.
    Wiggers, Theo
    Glimelius, Bengt
    BMC CANCER, 2013, 13
  • [4] Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
    Per J Nilsson
    Boudewijn van Etten
    Geke AP Hospers
    Lars Påhlman
    Cornelis JH van de Velde
    Regina GH Beets-Tan
    Lennart Blomqvist
    Jannet C Beukema
    Ellen Kapiteijn
    Corrie AM Marijnen
    Iris D Nagtegaal
    Theo Wiggers
    Bengt Glimelius
    BMC Cancer, 13
  • [5] Neoadjuvant chemotherapy (NAC) followed by total mesorectal excision (TME) and adjuvant chemotherapy versus TME followed by adjuvant chemotherapy in very low-lying clinical (c) T3 rectal cancer (NAIR): A multicenter, randomized, open-label, phase 2/3 trial.
    Tsukada, Yuichiro
    Kawashima, Yoshiyuki
    Fujita, Fumihiko
    Koda, Keiji
    Ohue, Masayuki
    Shinto, Eiji
    Murata, Akihiko
    Koide, Yoshikazu
    Nishizawa, Yuji
    Bando, Hideaki
    Suzuki, Motoko
    Misumi, Toshihiro
    Yoshino, Takayuki
    Saito, Norio
    Ito, Masaaki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
    Jii Bum Lee
    Han Sang Kim
    Inkyung Jung
    Sang Joon Shin
    Seung Hoon Beom
    Jee Suk Chang
    Woong Sub Koom
    Tae Il Kim
    Hyuk Hur
    Byung Soh Min
    Nam Kyu Kim
    Sohee Park
    Seung-Yong Jeong
    Jeong-Heum Baek
    Seon Hahn Kim
    Joon Seok Lim
    Kang Young Lee
    Joong Bae Ahn
    Trials, 21
  • [7] Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
    Lee, Jii Bum
    Kim, Han Sang
    Jung, Inkyung
    Shin, Sang Joon
    Beom, Seung Hoon
    Chang, Jee Suk
    Koom, Woong Sub
    Kim, Tae Il
    Hur, Hyuk
    Min, Byung Soh
    Kim, Nam Kyu
    Park, Sohee
    Jeong, Seung-Yong
    Baek, Jeong-Heum
    Kim, Seon Hahn
    Lim, Joon Seok
    Lee, Kang Young
    Ahn, Joong Bae
    TRIALS, 2020, 21 (01)
  • [8] Neoadjuvant short-course radiotherapy followed by chemotherapy plus camrelizumab versus long-course chemoradiotherapy followed by chemotherapy for patients with locally advanced rectal cancer: A randomized, multicenter, open-label phase 3 trial (Union)
    Lin, Zhenyu
    Zhang, Peng
    Hou, Zhiguo
    Tao, Kaixiong
    Zhang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
    Dijkstra, Esmee A.
    Hospers, Geke A. P.
    Kranenbarg, Elma Meershoek-Klein
    Fleer, Joke
    Roodvoets, Annet G. H.
    Bahadoer, Renu R.
    Guren, Marianne G.
    Tjalma, Jolien J. J.
    Putter, Hein
    Crolla, Rogier M. P. H.
    Hendriks, Mathijs P.
    Capdevila, Jaume
    Radu, Calin
    van de Velde, Cornelis J. H.
    Nilsson, Per J.
    Glimelius, Bengt
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 171 : 69 - 76
  • [10] Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION)
    Zhang, T.
    Tao, K.
    Lin, Z.
    Zhang, P.
    Yin, Y.
    Chi, P.
    Huang, Y.
    Xiao, Y.
    Sun, Z.
    Xu, X.
    Zhang, A.
    Qiu, X.
    Junxin, W.
    Yuan, Y.
    Wang, Z.
    Qu, X. J.
    Zhao, F.
    Ma, C.
    Cheng, F.
    Hou, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S1266 - S1267
12345